Correction: Survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitors.
Georges GebraelNicolas SayeghVinay Mathew ThomasBeverly ChigariraNishita TripathiYeon Jung JoHaoran LiKamal Kant SahuAyana SrivastavaTaylor McFarlandBenjamin L MaughanUmang SwamiArchana M AgarwalPublished in: Prostate cancer and prostatic diseases (2023)